Mechanism of Action / Class Flashcards
Altoprev
Lovastatin
HMG-CoA Reductase inhibitor which prevents the conversion of HMG-CoA to mevalonate
Rate limiting step of cholesterol synthesis
decreases LDL by 20 - 55%
Pravachol
Pravastatin
HMG-CoA Reductase inhibitor which prevents the conversion of HMG-CoA to mevalonate
Rate limiting step of cholesterol synthesis
Zocor
Simvastatin
HMG-CoA Reductase inhibitor which prevents the conversion of HMG-CoA to mevalonate
rate limiting step of cholesterol synthesis
decreases LDL by 20-55%
Zetia
Ezetimibe
inhibits ABSORPTION of cholesterol in the small instestine
decreases LDL by 18-23%
Praluent
Alirocumab
PSK9 inhibitor that blocks the defradation of LDL receptor
decreases LDL by 60%
Repatha
Evolocumab
PSK9 inhibitor that blocks the degradation of LDL receptor
decreases LDL by 60%!!!
Welchol
Colesevelam
Bile Acid Sequestrant
prevent the reabsorption of bile acids
decreases LDL by 10-30%
INCREASES TG :(
Cholestyramine
Bile Acid Sequestrant
prevent the reabsorption of bile acids
decreases LDL by 10-30%
INCREASES TG :(
Antara
Fenofibrate
PPARalpha receptor activators which upregulate the expression of ApoC-II = increaes lipoprotein lipase = increase catabolism of VLDL = DECREASE TG
decrease TG by 20-50%
Lopid
Gemfibrozil
PPARalpha receptor activators which upregulate the expression of ApoC-II = increaes lipoprotein lipase = increase catabolism of VLDL = DECREASE TG
decrease TG by 20-50%
Tricor
Fenofibrate
PPARalpha receptor activators which upregulate the expression of ApoC-II = increaes lipoprotein lipase = increase catabolism of VLDL = DECREASE TG
decrease TG by 20-50%
Trilipix
Fenofibrate
PPARalpha receptor activators which upregulate the expression of ApoC-II = increaes lipoprotein lipase = increase catabolism of VLDL = DECREASE TG
decrease TG by 20-50%
Niacin
decreases hepatic synthesis of VLDL and LDL
*increases HDL by 15-35%
Lovaza
Omega-3 acid ethyl ester
fish oil that decreases TG
***can increase LDL :(
Vascepa
Icosapent ethyl
fish oil that decreases TG
**can increase LDL
Zestoretic
Lisinopril / HTCZ
-ACE inhibitor block conversion of angiotensin I to II to decrease vasoconstriction and aldosterone secretion
- Thiazide inhibit sodium reabsorption in the distal convoluted tubule
Exforge
Valsartan / Amlodipine
-ARB block angiotensin II from binding to its receptor and preventing vasoconstriction
- DHP CCB inhibit Ca ions from entering vascular smooth muscle to decrease peripheral arterial pressure
Benicar HCT
Olmesartan / HTCZ
-ARB block angiotensin II from binding to its receptor and preventing vasoconstriction
- Thiazide inhibit sodium reabsorption in the distal convoluted tubule causing increased secretion of water, Na, Cl, and K
Diovan HCT
Valsartan / HTCZ
-ARB block angiotensin II from binding to its receptor and preventing vasoconstriction
- Thiazide inhibit sodium reabsorption in the distal convoluted tubule causing increased secretion of water, Na, Cl, and K
Ziac
Bisoprolol / HCTZ
- Beta- 1 selective beta blockers causes decrease in HR
**preferred in HF patients
- Thiazide inhibit sodium reabsorption in the distal convoluted tubule causing increased secretion of water, Na, Cl, and K
Maxzide, Dyazide
Triamterene / HTCZ
- Potassium sparing diuretic
- Thiazide inhibit sodium reabsorption in the distal convoluted tubule causing increased secretion of water, Na, Cl, and K
Tenoretic
Atenolol / Chlorthalidone
- beta 1 selective beta blockers cause decrease HR
- Thiazide inhibit sodium reabsorption in the distal convoluted tubule causing increased secretion of water, Na, Cl, and K
Lotrel
Benazepril / Amlodipine
-ACE inhibitor block conversion of angiotensin I to II to decrease vasoconstriction and aldosterone secretion
- DHP CCB inhibit Ca ions from entering vascular smooth muscle to decrease peripheral arterial pressure